A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts)

被引:0
|
作者
Winston, Drew J. [1 ]
Mullane, Kathleen M. [2 ]
Boeckh, Michael J. [3 ]
Cornely, Oliver A. [4 ]
Hurtado, Kimberly [5 ]
Su, Shu-Chih [5 ]
Pang, Lei [5 ]
Zhao, Yanli [5 ]
Chan, Ivan S. F. [5 ]
Stek, Jon E. [5 ]
Kaplan, Susan S. [5 ]
Parrino, Janie [5 ]
Annunziato, Paula [5 ]
Popmihajlov, Zoran [5 ]
Arvin, Ann [6 ]
机构
[1] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Univ Cologne, Cologne, Germany
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
6
引用
收藏
页码:S22 / S23
页数:2
相关论文
共 50 条
  • [41] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Liang Dai
    Linda L. D. Zhong
    Yan Cao
    Wei Chen
    Ying Cheng
    Xiu-Fang Lin
    Zhao-Xiang Bian
    Ai-Ping Lu
    Trials, 17
  • [42] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Qi Chen
    Zi Wang
    Jicheng Lv
    Lijun Liu
    Hang Li
    Weiwei Sun
    Yanhong Huo
    Yingbo Guo
    Cun Shen
    Shichao Li
    Zhenjie Chen
    Jingwei Zhou
    Trials, 23
  • [43] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Dai, Liang
    Zhong, Linda L. D.
    Cao, Yan
    Chen, Wei
    Cheng, Ying
    Lin, Xiu-Fang
    Bian, Zhao-Xiang
    Lu, Ai-Ping
    TRIALS, 2016, 17
  • [44] The Evaluation of Melatonin Effects on Mobilization and Engraftment in Autologous Hematopoietic Stem Cell Transplant Recipients; A Randomized, Double-blind and Placebo-controlled Trial
    Kazeminia, Neda
    Mehdizadeh, Mahshid
    Salamzadeh, Jamshid
    Parkhideh, Sayeh
    Dastan, Farzaneh
    Mahboubi, Arash
    Tavakoli-Ardakani, Maria
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (04): : 117 - 124
  • [45] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    Trials, 22
  • [46] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    TRIALS, 2021, 22 (01)
  • [47] Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study
    Ohta, Hiroyoshi
    Ohkura, Masayuki
    Suzuki, Makoto
    Oka, Hiroshi
    Usui, Chie
    Nishioka, Kusuki
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S792 - S792
  • [48] Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial
    Hu, Jialei
    Liu, Yueyue
    Liu, Shuo
    Shu, Qun
    Yang, Xuenan
    Chu, Kai
    Qiao, Yaping
    Hu, Yaling
    Wang, Kaiqin
    Pan, Hongxing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial
    Li, Yan-Ping
    Liang, Zheng-Lun
    Gao, Qiang
    Huang, Li-Rong
    Mao, Qun-Ying
    Wen, Shu-Qun
    Liu, Yan
    Yin, Wei-Dong
    Li, Rong-Cheng
    Wang, Jun-Zhi
    VACCINE, 2012, 30 (22) : 3295 - 3303
  • [50] Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
    Abarca, Katia
    Rey-Jurado, Emma
    Munoz-Durango, Natalia
    Vazquez, Yaneisi
    Soto, Jorge A.
    Galvez, Nicolas M. S.
    Valdes-Ferrada, Javier
    Iturriaga, Carolina
    Urzua, Marcela
    Borzutzky, Arturo
    Cerda, Jaime
    Villarroel, Luis
    Madrid, Victoria
    Gonzalez, Pablo A.
    Gonzalez-Aramundiz, Jose, V
    Bueno, Susan M.
    Kalergis, Alexis M.
    ECLINICALMEDICINE, 2020, 27